What Is MapLight Therapeutics, Inc. (MPLT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, MapLight Therapeutics, Inc.'s intrinsic value is estimated at $19.70, suggesting the stock is overvalued at its current price of $37.33. With 6 out of 7 models flagging downside (-47.2% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: First Chicago targets $42.04 (+12.6%), versus ML-RIV at $4.26 (-88.6%). This +101.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About MPLT?
7 of 13 models are currently active for MPLT. Of these, 1 model suggests upside while 6 models suggest overvaluation. The Bayesian DCF estimates MPLT's intrinsic value at $8.25, implying -77.9% downside from the current price. See which stocks rank higher →
How Does MPLT Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, MPLT ranks #225 by Quality of Company score. CirclFi's QOC score of 4.9/10 evaluates 32 fundamental signals. A score of 4.9 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, MapLight Therapeutics, Inc. operates in a sector where FDA approval probability is a critical driver of valuation. Investors evaluating MPLT should weigh these sector-specific dynamics alongside our model-derived fair values.
Is MPLT a Value Trap?
The Value Trap algorithm is not active for MPLT. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for MapLight Therapeutics, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, MapLight Therapeutics, Inc.'s fundamental quality profile registers 4.9/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +101.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MPLT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MPLT's 7 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad